共 93 条
[1]
Wilson P(1988)High density lipoprotein cholesterol and mortality. The Framingham Heart Study Arteriosclerosis: An Official Journal of the American Heart Association 8 737-41
[2]
Abbott RD(2004)High-density lipoprotein cholesterol and coronary heart disease Cardiol Rev 12 107-19
[3]
Castelli WP(2017)Evacetrapib and cardiovascular outcomes in high-risk vascular disease N Engl J Med 376 1933-42
[4]
Young CE(2017)Effects of anacetrapib in patients with atherosclerotic vascular disease N Engl J Med 377 1217-27
[5]
Karas RH(2016)High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART study J Am Coll Cardiol 68 2073-83
[6]
Kuvin JT(2017)Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies Eur Heart J 38 2478-86
[7]
Lincoff AM(2011)Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 127-35
[8]
Nicholls SJ(2009)The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis J Lipid Res 50 189-S194
[9]
Riesmeyer JS(2015)High-density lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease Arterioscler Thromb Vasc Biol 35 1515-9
[10]
Group HTRC(2019)HDL (high-density lipoprotein) cholesterol efflux capacity is associated with incident cardiovascular disease in the general population: a case-control study from the PREVEND cohort Arterioscler Thromb Vasc Biol 39 1874-83